Vaccines based on replication incompetent Ad26 viral vectors: Standardized template with key considerations for a risk/benefit assessment
暂无分享,去创建一个
Robert T. Chen | Roy G van Heesbeen | H. Schuitemaker | R. Condit | D. Heerwegh | J. Custers | E. Heijnen | M. Gurwith | M. Douoguih | J. Robertson | F. Tomaka | G. Shukarev | E. R. Smith | Denny Kim | M. Leyssen | Roy G. van Heesbeen | Eric Evans | Georgi Shukarev | Dirk Heerwegh | Maarten Leyssen